-- 週四下午晚些時候，金融股下跌，紐約證券交易所金融指數和道富金融精選行業SPDR ETF（XLF）均下跌0.2%。 費城住房指數下跌0.5%，道富房地產精選產業SPDR ETF（XLRE）上漲0.8%。 比特幣（BTC-USD）上漲0.4%至75,140美元，10年期美國公債殖利率上漲2.7個基點至4.309%。 經濟新聞方面，上周美國首次申請失業救濟人數從前一周向下修正後的21.8萬人降至20.7萬人，低於彭博社對分析師調查後預期的21.3萬人。 美國3月工業生產下降0.5%，低於彭博調查預期的0.1%增幅，2月的增幅經向上修正後為0.7%。 費城聯邦儲備銀行4月製造業指數上升至26.7，高於3月的18.1，而彭博調查預期該指數將降至10。 紐約聯邦儲備銀行4月服務業指數從3月的-22.6上升至-14，高於彭博調查預期的-20。 在監管方面，美國證券交易委員會（SEC）正在就一項全面審查「綜合審計追蹤」（Consolidated Audit Trail）及其他用於監管美國證券市場的類似審計追蹤系統徵求公眾意見。 公司方面，儘管營收低於華爾街預期，但嘉信理財（Charles Schwab，股票代號：SCHW）第一季業績在客戶資產激增的推動下有所增長。高盛(GS)股價下跌7.7%。 路透社通報，受伊朗相關市場波動的影響，高盛(GS)利率交易業務在第一季面臨壓力，部分持股出現虧損。報告稱，受利率交易、抵押貸款和信貸產品業績疲軟的影響，高盛固定收益、外匯和大宗商品收入下降10%至40億美元。高盛股價基本持平。 Marsh & McLennan (MRSH)股價上漲4.6%，此前該公司公佈的第一季調整後淨利潤和收入均超出分析師預期。 彭博社報道，美國國家籃球協會(NBA)正與包括阿波羅全球管理公司(APO)、Ares Management (ARES)和Sixth Street在內的多家私人信貸公司就潛在的歐洲籃球聯賽擴軍融資事宜進行初步磋商。阿波羅股價上漲0.1%，Ares股價下跌2.7%。
Related Articles
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
$HIG
Research
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
$BKR
Research
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.
$WAB